PN5
3 Inquiries
CAS No.:
1159861-00-3
Grade:
Pharmaceutical Grade
Content:
99.61%
Port:
shenzhen
Brand:
havhi
Packaging:
5mg/vial, 10vials/box
Price valid (until):
2026-09-18
Company Type:
Trader
Location:
China
Qualification:
Main Products:
Tirzepatide,Retatrutide,GHK-CU,NAD+,KPV,SS-31
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferencePNC-27 is an anti-cancer peptide that, in small in-vitro studies, has been shown to induce tumour cell necrosis. It is not currently approved for use in the United States (U.S.) and is currently being marketed online as a non-toxic potential cure for various cancers. Recently, the FDA issued warnings to the public regarding PNC-27 use, suggesting possible contamination and unknown side effects of the treatment. PNC-27 may be available in various dosage forms, such as a nebulized solution, intravenous solution, vaginal suppository, or rectal suppository. FDA has not evaluated or approved PNC-27 as safe and effective in treating any disease, including cancer[1].
PNC-27 is an anticancer peptide, containing an HDM-2-binding domain. PNC-27 shows anti-tumor activity and can be used in acute myeloid leukemia research.Basic Info-
Product Name:
PNC-27
Other Name:PNC27
CAS No.:1159861-00-3
Molecular Weight:0
Categories:
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,GHK-CU,NAD+,KPV,SS-31
-
Location:
1st Floor, Building 1, No. 2816 Yixian Road, Baoshan District, Shanghai
-
Year of Establishment:
2025
-
-
Inquiry History3 Inquiries
Country Product Purchase Quantity Date Posted 
United States
PNC27
10 PCS Apr 11, 2026
United States
PNC-27
1 PCS Sep 4, 2026
United States
PNC-27
5 MG Sep 4, 2026 Post an enquiry for this product
